🕵️ Sagimet Biosciences Inc. ($SGMT)
SEC insider & ownership activity, last 12 months · CIK 1400118 · every row links its SEC filing
Over the last 12 months insiders sold $4.9M with no open-market buying against it. Kemble George sold $4.2M through a 10b5-1 trading plan in 4 lots (Nov–Aug). 1 planned sale is pending, the largest $193K (George Kemble). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 5 sellers, $4.9M (10 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Kemble George | 0 | – | 4 | $4.2M | Aug 14, 2026 |
| Happel David | 0 | – | 2 | $562K | Jul 20, 2026 |
| Rozek Elizabeth | 0 | – | 2 | $96K | Jul 20, 2026 |
| Martins Eduardo Bruno | 0 | – | 1 | $20K | Feb 10, 2026 |
| Chauche Thierry | 0 | – | 1 | $7K | Feb 10, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.8% | Class A | 13G | Jul 30, 2026 | filing ↗ |
| Balyasny Asset Management L.P. | 5.9% | 13G | Aug 14, 2026 | filing ↗ | |
| BAM GP LLC | 5.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Balyasny Asset Management Holdings LP | 5.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Dames GP LLC | 5.9% | 13G | Aug 14, 2026 | filing ↗ | |
| Dmitry Balyasny | 5.9% | 13G | Aug 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| George Kemble | $3.3M | Aug 14, 2026 | filing ↗ |
| George Kemble | $193K | Aug 11, 2026 | filing ↗ |
| George Kemble | $147K | Jul 20, 2026 | filing ↗ |
| George Kemble | $296K | Nov 20, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Aug 13, 2026 | filing ↗ |
| Earnings (2.02) | Aug 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 12, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 28, 2026 | filing ↗ |
| Earnings (2.02) | May 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 12, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Earnings (2.02) | Apr 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 20, 2026 | filing ↗ |
| Other events (8.01) | Apr 20, 2026 | filing ↗ |
| Earnings (2.02) | Mar 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 11, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 11, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 18, 2025 | filing ↗ |
| Other events (8.01) | Dec 18, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 18, 2025 | filing ↗ |